Cargando…

Oxalate nephropathy induced by octreotide treatment for acromegaly: a case report

INTRODUCTION: Oxalate nephropathy has various etiologies and remains a rare cause of renal failure. To the best of our knowledge, we report the first case of oxalate nephropathy following octreotide therapy. CASE PRESENTATION: We report the case of a 78-year-old Caucasian man taking chronic octreoti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gariani, Karim, de Seigneux, Sophie, Courbebaisse, Marie, Lévy, Marc, Moll, Solange, Martin, Pierre-Yves
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416724/ https://www.ncbi.nlm.nih.gov/pubmed/22823940 http://dx.doi.org/10.1186/1752-1947-6-215

Ejemplares similares

Octreotide-Resistant Acromegaly: Challenges and Solutions
por: Corica, Giuliana, et al.
Publicado: (2020)

Effect of octreotide on endometriosis in acromegaly: Case report with review of literature
por: Singh, Seerat, et al.
Publicado: (2014)

Octreotide use for rescue of vision in a pregnant patient with acromegaly
por: Hannon, Anne Marie, et al.
Publicado: (2019)

Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly
por: Giustina, Andrea, et al.
Publicado: (2012)

Durable biochemical response and safety with oral octreotide capsules in acromegaly
por: Samson, Susan L, et al.
Publicado: (2022)

Oxalate Nephropathy
por: Etta, Praveen K., et al.
Publicado: (2023)

Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
por: Colao, A., et al.
Publicado: (2014)

Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine
por: Zhao, Jie, et al.
Publicado: (2023)

Diet-induced oxalate nephropathy
por: Clark, Barbara, et al.
Publicado: (2019)

Comparison of octreotide LAR and lanreotide autogel as post-operative medical treatment in acromegaly
por: Tutuncu, Yasemin, et al.
Publicado: (2011)

Breakdown of Autonomously Functioning Thyroid Nodule Accompanied by Acromegaly After Octreotide Treatment
por: Nomoto, Hiroshi, et al.
Publicado: (2019)

Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly
por: Marques-Pamies, Montserrat, et al.
Publicado: (2023)

Inhibitors of Calcium Oxalate Crystallization for the Treatment of Oxalate Nephropathies
por: Kletzmayr, Anna, et al.
Publicado: (2020)

Vitamin C-Induced Oxalate Nephropathy
por: Lamarche, Jorge, et al.
Publicado: (2011)

Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results
por: Labadzhyan, Artak, et al.
Publicado: (2021)

A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR® (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly
por: Mercado, Moises, et al.
Publicado: (2007)

Oxalate nephropathy: a review
por: Rosenstock, Jordan L, et al.
Publicado: (2021)

Vitamin C-induced oxalate nephropathy: a case report
por: Gurm, Harmeet, et al.
Publicado: (2012)

Purslane-induced oxalate nephropathy: case report and literature review
por: Wang, Xiangtuo, et al.
Publicado: (2023)

Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide
por: Samson, Susan L, et al.
Publicado: (2020)

Advanced acromegaly: successful disease control for more than 16 years using octreotide LA
por: Elshafie, Omayma, et al.
Publicado: (2020)

Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results
por: Labadzhyan, Artak, et al.
Publicado: (2021)

Vitamin C-Induced Oxalate Nephropathy in a Septic Patient
por: Wissanji, Tasheen, et al.
Publicado: (2021)

Acute oxalate nephropathy associated with orlistat
por: Humayun, Youshay, et al.
Publicado: (2016)

Hydroxocobalamin as a Cause of Oxalate Nephropathy
por: Legrand, Matthieu
Publicado: (2018)

Case report: a 58 -year -old man with small kidneys and elevated liver enzymes
por: Dash, Jonathan, et al.
Publicado: (2020)

Severe respiratory failure in a patient with COVID-19 and acromegaly: rapid improvement after adding octreotide
por: Luty, Jacob, et al.
Publicado: (2021)

Safety Results From MPOWERED, a Phase 3 Trial of Oral Octreotide Capsules in Adults With Acromegaly
por: Freda, Pamela, et al.
Publicado: (2021)

Efficacy and adverse events of octreotide long-acting release in acromegaly: a real-world retrospective study
por: Zhao, Zhe, et al.
Publicado: (2022)

A hidden cause of oxalate nephropathy: a case report
por: Mahmoud, Tala, et al.
Publicado: (2021)

Oxalate nephropathy: A three-dimensional view
por: Ward, Ashley, et al.
Publicado: (2015)

Secondary Oxalate Nephropathy: A Systematic Review
por: Lumlertgul, Nuttha, et al.
Publicado: (2018)

Etiologies, Clinical Features, and Outcome of Oxalate Nephropathy
por: Buysschaert, Benoit, et al.
Publicado: (2020)

Oxalate Nephropathy in an Oxalobacter formigenes–Negative Subject
por: Nazzal, Lama, et al.
Publicado: (2020)

Improved Acromegaly Patient Satisfaction With Oral Octreotide Capsules Compared With Injectable Somatostatin Receptor Ligands in the MPOWERED Trial
por: Gordon, Murray B, et al.
Publicado: (2021)

THU057 Predictors Of Response To Oral Octreotide Capsules In Patients With Acromegaly In A Large Prospective International Trial
por: Fleseriu, Maria, et al.
Publicado: (2023)

MPOWERED Trial Open-Label Extension: Long-term Efficacy and Safety Data for Oral Octreotide Capsules in Acromegaly
por: Fleseriu, Maria, et al.
Publicado: (2023)

Acute oxalate nephropathy following kidney transplantation: Report of three cases
por: Taheri, Diana, et al.
Publicado: (2015)

Ascorbic-acid/vitamin-d: Hypercalciuria and oxalate nephropathy: case report
Publicado: (2021)

Case report: Acute oxalate nephropathy due to traditional medicinal herbs
por: Wang, Lirui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bdok8ephok3qmfl6r20ukei75l